Published in Acta Oncol on August 01, 2010
LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor. Br J Cancer (2013) 0.95
Lrig2-deficient mice are protected against PDGFB-induced glioma. PLoS One (2013) 0.91
LRIG and cancer prognosis. Acta Oncol (2014) 0.87
The LRIG family: enigmatic regulators of growth factor receptor signaling. Endocr Relat Cancer (2014) 0.86
LRIG2 expression and prognosis in non-small cell lung cancer. Oncol Lett (2014) 0.86
In vivo analysis of Lrig genes reveals redundant and independent functions in the inner ear. PLoS Genet (2013) 0.84
Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer. Br J Cancer (2014) 0.82
Immunohistochemical LRIG3 expression in cervical intraepithelial neoplasia and invasive squamous cell cervical cancer: association with expression of tumor markers, hormones, high-risk HPV-infection, smoking and patient outcome. Eur J Histochem (2014) 0.77
Expression of LRIG1 is Associated With Good Prognosis for Human Non-small Cell Lung Cancer. Medicine (Baltimore) (2015) 0.76
The negative regulation of miR-149-5p in melanoma cell survival and apoptosis by targeting LRIG2. Am J Transl Res (2017) 0.75
Downregulation of LRIG2 expression inhibits angiogenesis of glioma via EGFR/VEGF-A pathway. Oncol Lett (2017) 0.75
Role and mechanism of action of LRIG1 in ovarian cancer cell line and VP16 drug-resistant cell line. Oncol Lett (2017) 0.75
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med (2014) 9.09
Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet (2009) 7.62
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol (2012) 5.71
Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology (2011) 5.17
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer. J Clin Oncol (2012) 2.45
Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res (2008) 2.24
LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J (2004) 2.20
Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res (2005) 2.11
Lymph nodes, tumor deposits, and TNM: are we getting better? J Clin Oncol (2011) 2.09
[Pediatric reference ranges for clinical chemistry analyzes]. Lakartidningen (2013) 1.99
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet (2010) 1.74
Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma. Cancer (2004) 1.70
Long-term results with tension-free vaginal tape on mixed and stress urinary incontinence. Obstet Gynecol (2005) 1.70
Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res (2005) 1.66
Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients. Gynecol Oncol (2002) 1.56
Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection. Int J Cancer (2002) 1.47
Verotoxin-1 induction of apoptosis in Gb3-expressing human glioma cell lines. Cancer Biol Ther (2006) 1.46
Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas. Acta Neuropathol (2004) 1.46
Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. Carcinogenesis (2008) 1.45
LRIG inhibitors of growth factor signalling - double-edged swords in human cancer? Eur J Cancer (2007) 1.44
A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer (2002) 1.43
Is LRIG1 a tumour suppressor gene at chromosome 3p14.3? Acta Oncol (2002) 1.34
Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol (2003) 1.32
Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. J Neurooncol (2003) 1.31
Comprehensive analysis of DNA repair gene variants and risk of meningioma. J Natl Cancer Inst (2008) 1.30
Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer (2003) 1.21
Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma. Virchows Arch (2005) 1.20
Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet (2007) 1.19
LRIG1 protein in human cells and tissues. Cell Tissue Res (2003) 1.18
The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea. Genomics (2004) 1.17
A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta Oncol (2010) 1.17
Dysregulated secretoglobin expression in human lung cancers. Lung Cancer (2003) 1.17
Common variation at 10p12.31 near MLLT10 influences meningioma risk. Nat Genet (2011) 1.12
Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomized, prospective study. Fertil Steril (2004) 1.10
Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors. Acta Neuropathol (2006) 1.10
Breast cancer multifocality, disease extent, and survival. Hum Pathol (2011) 1.10
An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol Biomarkers Prev (2007) 1.09
LRIG1 expression in colorectal cancer. Acta Oncol (2007) 1.08
Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden. J Neurooncol (2003) 1.05
Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. Cancer Res (2011) 1.05
Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival. Neuropathology (2009) 1.05
Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. Int J Radiat Oncol Biol Phys (2005) 1.04
Characterization and tissue-specific expression of human LRIG2. Gene (2004) 1.04
Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases. Am J Surg Pathol (2006) 1.03
Population-based pediatric reference intervals for hematology, iron and transferrin. Scand J Clin Lab Invest (2013) 1.02
The common D302H variant of CASP8 is associated with risk of glioma. Cancer Epidemiol Biomarkers Prev (2008) 1.02
LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer. Int J Cancer (2011) 1.01
ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases. Anticancer Res (2009) 1.01
Population-based pediatric reference intervals for general clinical chemistry analytes on the Abbott Architect ci8200 instrument. Clin Chem Lab Med (2012) 1.01
Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis. Eur J Cancer (2009) 1.00
Reference intervals on the Abbot Architect for serum thyroid hormones, lipids and prolactin in healthy children in a population-based study. Scand J Clin Lab Invest (2012) 1.00
Population-based pediatric reference intervals for HbA1c, bilirubin, albumin, CRP, myoglobin and serum enzymes. Scand J Clin Lab Invest (2013) 1.00
Frequency of de novo urgency in 463 women who had undergone the tension-free vaginal tape (TVT) procedure for genuine stress urinary incontinence--a long-term follow-up. Eur J Obstet Gynecol Reprod Biol (2006) 0.99
Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma. Neuroepidemiology (2002) 0.99
Mutation of PIK3CA: possible risk factor for cervical carcinogenesis in older women. Int J Oncol (2009) 0.99
Low-oxygen compared with high-oxygen atmosphere in blastocyst culture, a prospective randomized study. Fertil Steril (2008) 0.98
Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev (2008) 0.97
Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma. J Neurooncol (2006) 0.97
Increased copy number at 3p14 in breast cancer. Breast Cancer Res (2005) 0.97
MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome. Int J Cancer (2009) 0.97
Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity. Acta Oncol (2011) 0.97
Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma. Int J Oncol (2012) 0.96
Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers. Clin Breast Cancer (2003) 0.95
An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol Biomarkers Prev (2007) 0.95
Pharmacological modulation of lung cancer cells for potassium ion depletion. Anticancer Res (2005) 0.92
PAI-1 -675 4G/5G polymorphism as a prognostic biomarker in breast cancer. Breast Cancer Res Treat (2007) 0.92
Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1. Exp Cell Res (2010) 0.92
Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival. Breast Cancer Res Treat (2011) 0.92
Lrig2-deficient mice are protected against PDGFB-induced glioma. PLoS One (2013) 0.91
Hypofractionated conformal stereotactic radiotherapy for arteriovenous malformations. Neurosurgery (2003) 0.91
Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer. Anticancer Res (2012) 0.91
Multifocal breast cancer documented in large-format histology sections: long-term follow-up results by molecular phenotypes. Cancer (2012) 0.91
Markers of Celiac Disease and Gluten Sensitivity in Children with Autism. PLoS One (2013) 0.90
p53 Genotypes and risk of glioma and meningioma. Cancer Epidemiol Biomarkers Prev (2005) 0.89
Significant cytotoxic activity in vitro of the EGFR tyrosine kinase inhibitor gefitinib in acute myeloblastic leukaemia. Eur J Haematol (2008) 0.89
Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study. J Neurooncol (2005) 0.89
Synergistic killing of glioblastoma stem-like cells by bortezomib and HDAC inhibitors. Anticancer Res (2012) 0.89
Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage. Gynecol Oncol (2004) 0.89
Effects of the VEGFR inhibitor ZD6474 in combination with radiotherapy and temozolomide in an orthotopic glioma model. J Neurooncol (2008) 0.89
Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy. J Neurooncol (2008) 0.89
Inhibition of the epidermal growth factor receptor enhances castration-induced prostate involution and reduces testosterone-stimulated prostate growth in adult rats. Prostate (2007) 0.89
Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma. BMC Res Notes (2012) 0.88
Mammaglobin in normal human sweat glands and human sweat gland tumors. J Invest Dermatol (2003) 0.88
Oral contraceptive and progestin-only use correlates to tissue tumor marker expression in women with cervical intraepithelial neoplasia. Contraception (2011) 0.88
Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study. Int J Cancer (2012) 0.88
ErbB4 is downregulated in renal cell carcinoma--a quantitative RT-PCR and immunohistochemical analysis of the epidermal growth factor receptor family. Acta Oncol (2004) 0.88
A specialist nurse as a resource for family members to patients with brain tumors: an action research study. Cancer Nurs (2008) 0.87
Genetic variations in EGF and EGFR and glioblastoma outcome. Neuro Oncol (2010) 0.87
Metabolic manipulation of glioblastoma in vivo by retrograde microdialysis of L-2, 4 diaminobutyric acid (DAB). J Neurooncol (2006) 0.87
Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study. Mod Pathol (2009) 0.87
LRIG and cancer prognosis. Acta Oncol (2014) 0.87
EGFR gene variants are associated with specific somatic aberrations in glioma. PLoS One (2012) 0.86
[Registration on regional basis of patients with primary brain tumors. Regional differences disclosed]. Lakartidningen (2007) 0.86